Selected research
Industry Research
Mesna (Mesnex) Industry Research Report 2026
Market perspective
The global Mesna (Mesnex) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Mesna (Mesnex) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Mesna (Mesnex) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Mesna (Mesnex) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Mesna (Mesnex) include Teva Pharmaceutical, Mylan, Jiangsu Hengrui Medicine, Fresenius Kabi, Baxter, Sagent Pharmaceuticals, Hikma Pharmaceuticals, Gland Pharma Limited and Athenex Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Mesna (Mesnex) market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mesna (Mesnex) Market by Company
Teva Pharmaceutical
Mylan
Jiangsu Hengrui Medicine
Fresenius Kabi
Baxter
Sagent Pharmaceuticals
Hikma Pharmaceuticals
Gland Pharma Limited
Athenex Pharmaceuticals
Mesna (Mesnex) Segment by Type
Oral
Injections
Mesna (Mesnex) Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Mesna (Mesnex) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesna (Mesnex) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mesna (Mesnex) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesna (Mesnex).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Mesna (Mesnex) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Mesna (Mesnex) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Mesna (Mesnex) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injections
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Teva Pharmaceutical
- Mylan
- Jiangsu Hengrui Medicine
- Fresenius Kabi
- Baxter
- Sagent Pharmaceuticals
- Hikma Pharmaceuticals
- Gland Pharma Limited
- Athenex Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Mesna (Mesnex) Market Size (2021-2032)
- 2.2.2 Global Mesna (Mesnex) Sales (2021-2032)
- 2.2.3 Global Mesna (Mesnex) Market Average Price (2021-2032)
- 2.3 Mesna (Mesnex) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral
- 2.3.3 Injections
- 2.4 Mesna (Mesnex) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Hospital Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Mesna (Mesnex) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Mesna (Mesnex) Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Mesna (Mesnex) Revenue of Manufacturers (2021-2026)
- 3.4 Global Mesna (Mesnex) Average Price by Manufacturers (2021-2026)
- 3.5 Global Mesna (Mesnex) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Mesna (Mesnex), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Mesna (Mesnex), Product Type & Application
- 3.8 Global Manufacturers of Mesna (Mesnex), Established Date
- 3.9 Global Mesna (Mesnex) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical
- 4.1.1 Teva Pharmaceutical Company Information
- 4.1.2 Teva Pharmaceutical Business Overview
- 4.1.3 Teva Pharmaceutical Mesna (Mesnex) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Mesna (Mesnex) Product Portfolio
- 4.1.5 Teva Pharmaceutical Recent Developments
- 4.2 Mylan
- 4.2.1 Mylan Company Information
- 4.2.2 Mylan Business Overview
- 4.2.3 Mylan Mesna (Mesnex) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mylan Mesna (Mesnex) Product Portfolio
- 4.2.5 Mylan Recent Developments
- 4.3 Jiangsu Hengrui Medicine
- 4.3.1 Jiangsu Hengrui Medicine Company Information
- 4.3.2 Jiangsu Hengrui Medicine Business Overview
- 4.3.3 Jiangsu Hengrui Medicine Mesna (Mesnex) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangsu Hengrui Medicine Mesna (Mesnex) Product Portfolio
- 4.3.5 Jiangsu Hengrui Medicine Recent Developments
- 4.4 Fresenius Kabi
- 4.4.1 Fresenius Kabi Company Information
- 4.4.2 Fresenius Kabi Business Overview
- 4.4.3 Fresenius Kabi Mesna (Mesnex) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Fresenius Kabi Mesna (Mesnex) Product Portfolio
- 4.4.5 Fresenius Kabi Recent Developments
- 4.5 Baxter
- 4.5.1 Baxter Company Information
- 4.5.2 Baxter Business Overview
- 4.5.3 Baxter Mesna (Mesnex) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Baxter Mesna (Mesnex) Product Portfolio
- 4.5.5 Baxter Recent Developments
- 4.6 Sagent Pharmaceuticals
- 4.6.1 Sagent Pharmaceuticals Company Information
- 4.6.2 Sagent Pharmaceuticals Business Overview
- 4.6.3 Sagent Pharmaceuticals Mesna (Mesnex) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sagent Pharmaceuticals Mesna (Mesnex) Product Portfolio
- 4.6.5 Sagent Pharmaceuticals Recent Developments
- 4.7 Hikma Pharmaceuticals
- 4.7.1 Hikma Pharmaceuticals Company Information
- 4.7.2 Hikma Pharmaceuticals Business Overview
- 4.7.3 Hikma Pharmaceuticals Mesna (Mesnex) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hikma Pharmaceuticals Mesna (Mesnex) Product Portfolio
- 4.7.5 Hikma Pharmaceuticals Recent Developments
- 4.8 Gland Pharma Limited
- 4.8.1 Gland Pharma Limited Company Information
- 4.8.2 Gland Pharma Limited Business Overview
- 4.8.3 Gland Pharma Limited Mesna (Mesnex) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Gland Pharma Limited Mesna (Mesnex) Product Portfolio
- 4.8.5 Gland Pharma Limited Recent Developments
- 4.9 Athenex Pharmaceuticals
- 4.9.1 Athenex Pharmaceuticals Company Information
- 4.9.2 Athenex Pharmaceuticals Business Overview
- 4.9.3 Athenex Pharmaceuticals Mesna (Mesnex) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Athenex Pharmaceuticals Mesna (Mesnex) Product Portfolio
- 4.9.5 Athenex Pharmaceuticals Recent Developments
5 Global Mesna (Mesnex) Market Scenario by Region
- 5.1 Global Mesna (Mesnex) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Mesna (Mesnex) Sales by Region: 2021-2032
- 5.2.1 Global Mesna (Mesnex) Sales by Region: 2021-2026
- 5.2.2 Global Mesna (Mesnex) Sales by Region: 2027-2032
- 5.3 Global Mesna (Mesnex) Revenue by Region: 2021-2032
- 5.3.1 Global Mesna (Mesnex) Revenue by Region: 2021-2026
- 5.3.2 Global Mesna (Mesnex) Revenue by Region: 2027-2032
- 5.4 North America Mesna (Mesnex) Market Facts & Figures by Country
- 5.4.1 North America Mesna (Mesnex) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Mesna (Mesnex) Sales by Country (2021-2032)
- 5.4.3 North America Mesna (Mesnex) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Mesna (Mesnex) Market Facts & Figures by Country
- 5.5.1 Europe Mesna (Mesnex) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Mesna (Mesnex) Sales by Country (2021-2032)
- 5.5.3 Europe Mesna (Mesnex) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Mesna (Mesnex) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Mesna (Mesnex) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Mesna (Mesnex) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Mesna (Mesnex) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Mesna (Mesnex) Market Facts & Figures by Country
- 5.7.1 South America Mesna (Mesnex) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Mesna (Mesnex) Sales by Country (2021-2032)
- 5.7.3 South America Mesna (Mesnex) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Mesna (Mesnex) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Mesna (Mesnex) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Mesna (Mesnex) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Mesna (Mesnex) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Mesna (Mesnex) Sales by Type (2021-2032)
- 6.1.1 Global Mesna (Mesnex) Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Mesna (Mesnex) Sales Market Share by Type (2021-2032)
- 6.2 Global Mesna (Mesnex) Revenue by Type (2021-2032)
- 6.2.1 Global Mesna (Mesnex) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Mesna (Mesnex) Revenue Market Share by Type (2021-2032)
- 6.3 Global Mesna (Mesnex) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Mesna (Mesnex) Sales by Application (2021-2032)
- 7.1.1 Global Mesna (Mesnex) Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Mesna (Mesnex) Sales Market Share by Application (2021-2032)
- 7.2 Global Mesna (Mesnex) Revenue by Application (2021-2032)
- 7.2.1 Global Mesna (Mesnex) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Mesna (Mesnex) Revenue Market Share by Application (2021-2032)
- 7.3 Global Mesna (Mesnex) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Mesna (Mesnex) Value Chain Analysis
- 8.1.1 Mesna (Mesnex) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Mesna (Mesnex) Production Mode & Process
- 8.2 Mesna (Mesnex) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Mesna (Mesnex) Distributors
- 8.2.3 Mesna (Mesnex) Customers
9 Global Mesna (Mesnex) Analyzing Market Dynamics
- 9.1 Mesna (Mesnex) Industry Trends
- 9.2 Mesna (Mesnex) Industry Drivers
- 9.3 Mesna (Mesnex) Industry Opportunities and Challenges
- 9.4 Mesna (Mesnex) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst